Evidence map›Paper›PMID 21482686›Full record

ArticleInfection and immunity2011

Role of gastric epithelial cell-derived transforming growth factor beta in reduced CD4+ T cell proliferation and development of regulatory T cells during Helicobacter pylori infection.

Ellen J Beswick, Iryna V Pinchuk, Rachel B Earley, David A Schmitt, Victor E Reyes

Abstract read
In one paragraph

Article in Infection and immunity, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 51 citations in OpenAlex.

  1. TGF-β signaling in health, disease, and therapeutics.Signal transduction and targeted therapy · 2024
    Review
  2. Review
  3. Microorganisms · 2023
    Review
  4. Medical research archives · 2022
    Article
  5. Review
  6. Review
  7. Article
  8. Clinical oncology and research · 2019
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Influence of TGFB1 C-509T polymorphism on gastric cancer risk associated with TGF-β1 expression in the gastric mucosa.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2015
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ellen J BeswickDepartments of Molecular Genetics and Microbiology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico 87131,USA. ebeswick@salud.unm.edu
Iryna V Pinchuk
Rachel B Earley
David A Schmitt
Victor E Reyes
The University of Texas Medical Branch at Galveston · USUniversity of New Mexico · US

Funding

UNIVERSITY OF NEW MEXICO CLINICAL AND TRANSLATIONAL SCIENCE CENTERUL1RR031977 · NCRR · UNIVERSITY OF NEW MEXICO · PI LARSON, RICHARD S · 2010 to 2011
$8.8M
IMPAIRED TUMOR IMMUNITY DURING H PYLORI INFECTIONR01DK050669 · NIDDK · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI REYES, VICTOR E · 1995 to 2003
$1.1M
Immune Evasion by H. pyloriR56DK090090 · NIDDK · UNIVERSITY OF TEXAS MED BR GALVESTON · PI REYES, VICTOR E. · 2010 to 2010
$395k
Protein Biomarkers of Gastric CancerR21CA127022 · NCI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI REYES, VICTOR E. · 2009 to 2010
$365k
Potential Role of H. Pylori-induced MIF in Gastric CancerK22AI068712 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BESWICK, ELLEN J. · 2008 to 2009
$269k
NCI NIH HHS R21 CA127022NCI NIH HHS R21CA127022NCRR NIH HHS 1UL1RR031977-01NCRR NIH HHS UL1 RR031977NIAID NIH HHS K22 AI068712NIAID NIH HHS K22AI68712NIDDK NIH HHS R01 DK050669NIDDK NIH HHS R56 DK090090NIDDK NIH HHS R56DK090090-01
6 · The paper itself

Abstract

Gastric epithelial cells (GECs) express the class II major histocompatibility complex (MHC) and costimulatory molecules, enabling them to act as antigen-presenting cells (APCs) and affect local T cell responses. During Helicobacter pylori infection, GECs respond by releasing proinflammatory cytokines and by increasing the surface expression of immunologically relevant receptors, including class II MHC. The CD4(+) T cell response during H. pylori infection is skewed toward a Th1 response, but these cells remain hyporesponsive. Activated T cells show decreased proliferation during H. pylori infection, and CD4(+) CD25(+) FoxP3(+) regulatory T cells (Tregs) are present at the site of infection. In this study, we examined the mechanisms surrounding the CD4(+) T cell responses during H. pylori infection and found that transforming growth factor β (TGF-β) plays a major role in these responses. GECs produced TGF-β1 and TGF-β2 in response to infection. Activated CD4(+) T cells in culture with H. pylori-treated GECs were decreased in proliferation but increased upon neutralization of TGF-β. Naïve CD4(+) T cell development into Tregs was also enhanced in the presence of GEC-derived TGF-β. Herein, we demonstrate a role for GEC-produced TGF-β in the inhibition of CD4(+) T cell responses seen during H. pylori infection.

Indexed as

Helicobacter pyloriAntigen-Presenting CellsCD4-Positive T-LymphocytesCell Line, TumorCell ProliferationCytokinesEpithelial CellsFlow CytometryGastric MucosaGenes, MHC Class IIHelicobacter InfectionsHumansInterleukin-2 Receptor alpha SubunitLymphocyte ActivationPolymerase Chain ReactionStomach NeoplasmsCytokinesInterleukin-2 Receptor alpha SubunitTransforming Growth Factor beta

Identifiers

PMID21482686
PMCPMC3191950
OpenAlexW2061613081

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.